Skip to content
Open access

Genetically Proxied GIP‐GIPR Pathway Perturbation and Fracture Risk

Sep 2026 · Diabetes, obesity and metabolism · Vol 28, pp. 11839 - 11850 · 0 citations · 37 references
Medicine

Abstract

To determine whether genetic proxies for incretin pathway perturbation are associated with fracture risk and bone mineral density, providing human genetic evidence relevant to the skeletal safety of incretin‐based therapies.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.